- Home
- ASPN vs ELVN Comparison
ASPN vs ELVN Comparison
Compare ASPN & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPN
- ELVN
- Stock Information
- Founded
- ASPN 2001
- ELVN 2016
- Country
- ASPN United States
- ELVN United States
- Employees
- ASPN N/A
- ELVN N/A
- Industry
- ASPN RETAIL: Building Materials
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- ASPN Consumer Discretionary
- ELVN Health Care
- Exchange
- ASPN Nasdaq
- ELVN Nasdaq
- Market Cap
- ASPN 1.1B
- ELVN 1.1B
- IPO Year
- ASPN 2014
- ELVN 2020
- Fundamental
- Price
- ASPN $12.73
- ELVN $21.47
- Analyst Decision
- ASPN Strong Buy
- ELVN Strong Buy
- Analyst Count
- ASPN 10
- ELVN 5
- Target Price
- ASPN $30.00
- ELVN $37.80
- AVG Volume (30 Days)
- ASPN 1.6M
- ELVN 246.0K
- Earning Date
- ASPN 02-10-2025
- ELVN 03-13-2025
- Dividend Yield
- ASPN N/A
- ELVN N/A
- EPS Growth
- ASPN N/A
- ELVN N/A
- EPS
- ASPN 0.02
- ELVN N/A
- Revenue
- ASPN $413,830,000.00
- ELVN N/A
- Revenue This Year
- ASPN $92.45
- ELVN N/A
- Revenue Next Year
- ASPN $11.22
- ELVN N/A
- P/E Ratio
- ASPN $698.56
- ELVN N/A
- Revenue Growth
- ASPN 93.28
- ELVN N/A
- 52 Week Low
- ASPN $10.75
- ELVN $10.90
- 52 Week High
- ASPN $33.15
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- ASPN 45.83
- ELVN 42.14
- Support Level
- ASPN $12.11
- ELVN $20.16
- Resistance Level
- ASPN $13.28
- ELVN $23.08
- Average True Range (ATR)
- ASPN 0.70
- ELVN 1.60
- MACD
- ASPN 0.14
- ELVN -0.09
- Stochastic Oscillator
- ASPN 41.98
- ELVN 25.14
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.